Inventor
Serguei Nabirochkin
Inventor
Chatenay Malabry, FR
Overview
Patents· 48 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes52%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations35%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms3%
G01NInvestigating or analysing materials by determining their chemical or physical properties3%
C07CAcyclic or carbocyclic compounds2%
C07DHeterocyclic compounds2%
Y10TTechnical subjects covered by former us classification2%
PatentTitleYear
10,940,147Early treatment of CMT disease202110,905,686Compositions for treating CMT and related disorders202110,905,672Combination of baclofen, acamprosate and medium chain triglycerides for the treatment of neurological disorders202110,874,644Therapeutic approaches for treating Alzheimer disease and related disorders through a modulation of synapse function202010,849,851Stable oral solutions for combined API202010,736,876Idalopirdine-based combinatorial therapies of Alzheimer's disease202010,682,342Compositions for treating amyotrophic lateral sclerosis202010,617,689Compositions, methods and uses for the treatment of diabetes and related conditions by controlling blood glucose level202010,596,160Compositions, methods and uses for the treatment of diabetes and related conditions by controlling blood glucose level202010,583,135Compositions for treating CMT and related disorders202010,463,640Therapeutic approaches for treating CMT and related disorders201910,441,558Therapeutic approaches for treating CMT and related disorders201910,434,109Compositions for treating neurological disorders201910,383,870Early treatment of CMT disease201910,350,195Therapeutic approaches for treating Alzheimer disease and related disorders through a modulation of synapse function201910,342,784Compositions for treating amyotrophic lateral sclerosis201910,342,768Therapeutic approaches for treating Parkinson's disease201910,322,101Therapeutic approaches for treating CMT and related disorders201910,300,015Stable oral solutions for combined API201910,265,304Nootropic compositions for improving memory performance201910,092,554Compositions, methods and uses for the treatment of diabetes and related conditions by controlling blood glucose level201810,045,971Compositions for treating amyotrophic lateral sclerosis201810,010,515Therapeutic approaches for treating Parkinson's disease201810,004,744Therapeutic approaches for treating Parkinson's disease20189,945,876Diagnostic tools for charcot-marie-tooth disease20189,931,326Composition comprising torasemide and baclofen for treating neurological disorders20189,867,837'Compositions for treating neurological disorders'20189,820,978'Treatment of cerebral ischemia'20179,789,098'Nootropic compositions for improving memory performance'20179,636,316'Baclofen and acamprosate based therapy of neurological disorders'20179,597,297'Combination of pilocarpin and methimazol for treating Charcot-Marietooth disease and related disorders'20179,566,275'Compositions for treating CMT and related disorders'20179,545,389'Baclofen and acamprosate based therapy of macular degeneration disorders'20179,494,605'Diagnostic tools for charcot-marie-tooth disease'20169,493,834'Method for detecting a panel of biomarkers'20169,427,436'Compositions for treating CMT and related disorders'20169,393,241'Compositions for treating CMT and related disorders'20169,387,206'Therapeutic approaches for treating Alzheimer\'s disease'20169,248,111'Therapeutic approaches for treating parkinson\'s disease'20169,241,933'Compositions for treating amyotrophic lateral sclerosis'20169,144,558'Baclofen and acamprosate based therapy of neurological disorders'20158,992,891'Therapeutic approaches for treating CMT and related disorders'20158,865,769'Baclofen and acamprosate based therapy of neurological disorders'20148,809,302'Therapeutic approaches for treating alzheimer\'S disease'20148,741,886'Baclofen and acamprosate based therapy of neurological disorders'20148,716,269'Combination of pilocarpin and methimazol for treating Charcot-Marietooth disease and related disorders'20148,642,566'Therapeutic approaches for treating neuroinflammatory conditions'20148,552,041'Therapeutic approaches for treating alzheimer disease and related disorders through a modulation of cell stress response'2013Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2013–2021Patents assigned to PHARNEXT (48)· patent assignee history
2013–2017Patents assigned to CHUMAKOV ILYA (8)· patent assignee history
2013–2017Patents assigned to COHEN DANIEL (8)· patent assignee history
2013–2017Patents assigned to NABIROCHKIN SERGUEI (8)· patent assignee history
2013–2016Patents assigned to GUERASSIMENKO OXANA (4)· patent assignee history
2013–2021Based in Chatenay Malabry, FR· patent location history
2020Based in Catenay Malabry, FR· patent location history
2020Based in Chateney Malabry, FR· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| PHARNEXT | 48 | 2013–2021 |
| CHUMAKOV ILYA | 8 | 2013–2017 |
| COHEN DANIEL | 8 | 2013–2017 |
| NABIROCHKIN SERGUEIself | 8 | 2013–2017 |
| GUERASSIMENKO OXANA | 4 | 2013–2016 |
Locations
| Location | Patents | Span |
|---|---|---|
| Chatenay Malabry, FR | 46 | 2013–2021 |
| Catenay Malabry, FR | 1 | 2020 |
| Chateney Malabry, FR | 1 | 2020 |